Switch theme
Sign up to access all valuation multiples
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
2007
62
LTM Revenue $236M
LTM EBITDA $49.8M
$485M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Atrys Health has a last 12-month revenue of $236M and a last 12-month EBITDA of $49.8M.
In the most recent fiscal year, Atrys Health achieved revenue of $229M and an EBITDA of $20.5M.
Atrys Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Atrys Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $217M | $229M | XXX | XXX | XXX |
| Gross Profit | $166M | $152M | XXX | XXX | XXX |
| Gross Margin | 77% | 67% | XXX | XXX | XXX |
| EBITDA | $31.2M | $20.5M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 9% | XXX | XXX | XXX |
| Net Profit | -$25.0M | -$49.0M | XXX | XXX | XXX |
| Net Margin | -12% | -21% | XXX | XXX | XXX |
| Net Debt | $180M | $192M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Atrys Health's stock price is EUR 3 (or $3).
Atrys Health has current market cap of EUR 216M (or $232M), and EV of EUR 451M (or $485M).
See Atrys Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $485M | $232M | XXX | XXX | XXX | XXX | $-0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Atrys Health has market cap of $232M and EV of $485M.
Atrys Health's trades at 2.1x LTM EV/Revenue multiple, and 9.7x LTM EBITDA.
Analysts estimate Atrys Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Atrys Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $485M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 23.7x | XXX | XXX | XXX |
| P/E | -6.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -44.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAtrys Health's NTM/LTM revenue growth is 8%
Atrys Health's revenue per employee for the last fiscal year averaged $3.7M, while opex per employee averaged $2.3M for the same period.
Over next 12 months, Atrys Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Atrys Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Atrys Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -34% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 17% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $3.7M | XXX | XXX | XXX | XXX |
| Opex per Employee | $2.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 63% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Atrys Health acquired XXX companies to date.
Last acquisition by Atrys Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Atrys Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Atrys Health founded? | Atrys Health was founded in 2007. |
| Where is Atrys Health headquartered? | Atrys Health is headquartered in Spain. |
| How many employees does Atrys Health have? | As of today, Atrys Health has 62 employees. |
| Who is the CEO of Atrys Health? | Atrys Health's CEO is Ms. Isabel Lozano Fernandez. |
| Is Atrys Health publicy listed? | Yes, Atrys Health is a public company listed on MAD. |
| What is the stock symbol of Atrys Health? | Atrys Health trades under ATRY ticker. |
| When did Atrys Health go public? | Atrys Health went public in 2016. |
| Who are competitors of Atrys Health? | Similar companies to Atrys Health include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Atrys Health? | Atrys Health's current market cap is $232M |
| What is the current revenue of Atrys Health? | Atrys Health's last 12-month revenue is $236M. |
| What is the current EBITDA of Atrys Health? | Atrys Health's last 12-month EBITDA is $49.8M. |
| What is the current EV/Revenue multiple of Atrys Health? | Current revenue multiple of Atrys Health is 2.1x. |
| What is the current EV/EBITDA multiple of Atrys Health? | Current EBITDA multiple of Atrys Health is 9.7x. |
| What is the current revenue growth of Atrys Health? | Atrys Health revenue growth between 2023 and 2024 was 6%. |
| Is Atrys Health profitable? | Yes, Atrys Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
